New groundbreaking research by Stanford researchers has shown to do something that was previously believed not possible: ...

People living with osteoarthritis often have questions about their condition, but they do not always have easy access to ...

IND Filing and Concurrent RMAT Request Position XytriX™ as a Potential Breakthrough Biotherapeutic for More Than 500 ...

Despite its enormous global burden, osteoarthritis has no licensed disease-modifying treatments, and available analgesics have moderate efficacy and substantial side-effects.1 The success of ...

Osteoarthritis, a condition that causes pain and reduced mobility in joints such as the knees and fingers, is one of the most ...

Novel agent outperforms placebo in phase II trial, but is it enough?

Can-Fite Signed a Deal Worth up to $325M with the Veterinary Company VetbiolixRamat Gan, Israel, March 30, 2026 (GLOBE NEWSWIRE) -- Can-Fite ...

Episcopal Health Services announced on Tuesday, March 24, that it is now offering low-dose radiotherapy using its new ...

Significant improvements in pain, function and patient global outcomes demonstrated LEVI-04 well tolerated and exhibits a favourable safety ...

Study findings suggest that ixekizumab provides balanced joint and skin improvements with comparable treatment persistence to other b/tsDMARDs in routine PsA care.

A major analysis of nearly 10,000 patients shows that simple, non-drug treatments like knee braces, hydrotherapy, and exercise can significantly ease knee osteoarthritis symptoms. These approaches not ...

U.S. President Donald Trump secured agreements with 16 major pharmaceutical companies to bring U.S. prescription drug prices ...